| Document Date: 2014-09-19 05:20:51 Open Document File Size: 18,19 KBShare Result on Facebook
City Osaka / / Company Press Release Mitsubishi Tanabe Pharma Corporation / Mitsubishi Tanabe Pharma Corporation / / Country Japan / / Event FDA Phase / / MedicalCondition HCV genotype 1 / HCV genotype 2 / chronic hepatitis C / hepatitis C / HCV / / Person Masayuki Mitsuka / / / Position Director / CEO / President & Representative / / Product ribavirin / TELAVIC® / / Technology Genotype / /
SocialTag |